๐๐ฌ ๐ฒ๐จ๐ฎ๐ซ ๐ซ๐จ๐ฅ๐ ๐๐-๐๐จ๐๐ฎ๐ฌ๐๐? ๐๐ซ๐ ๐ฒ๐จ๐ฎ ๐ฅ๐จ๐จ๐ค๐ข๐ง๐ ๐๐จ๐ซ ๐๐ฑ๐๐ข๐ญ๐ข๐ง๐ ๐ง๐๐ฐ ๐ฐ๐๐ฒ๐ฌ ๐ญ๐จ ๐ ๐๐ง๐๐ซ๐๐ญ๐ ๐ก๐ข๐ ๐ก-๐ฏ๐๐ฅ๐ฎ๐ ๐๐๐?
Weโre getting the word out early – Quantify is excited to attend its first US ISPOR this year in Boston, during May 7-10! We would love to connect and discuss how Nordic and other European RWD can be used to support your regulatory and commercial needs. Here is a teaser for what you can expect from Nordic data:
๐ Full population coverage (not just population-based!) of the 27+ million residents
๐ Patient-level linkable data spanning diagnoses, prescriptions, mortality cause and date, demographics, socioeconomics, labs, genetic information, severity, PROMs, and work loss
๐ Decades of patient follow-up
๐ No loss to follow-up
๐ Real use cases supporting manufacturersโ US commercial and regulatory evidence base
As a complement to RWE, or stand-alone, we also provide services in economic modelling, visualization, literature review, and meta-analysis.
Get in touch to start the conversation and let us know what info, insights, or services you might be interested in exploring:ย info@quantifyresearch.com
#RWEย #RWDย #realworldevidenceย #realworlddataย #ISPORย #QuantifyResearchย #regulatoryย #commercializationย #pharmaย #dataย #Nordicsย #Europe